Kristi A Egland

Title: Kristi A. Egland: Innovator in Immunoglobulin Research

Introduction

Kristi A. Egland is a prominent inventor based in Sioux Falls, SD (US). She has made significant contributions to the field of immunology, particularly in the development of treatments for coronavirus disease. Her innovative work has led to the creation of valuable therapeutic products.

Latest Patents

Kristi holds a patent for "Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof." This patent provides human polyclonal immunoglobulin products designed for treating or preventing coronavirus disease. The methods outlined in her patent involve creating such compositions in a transgenic ungulate, specifically utilizing a transchromosomic bovine (TcB) system. She has 1 patent to her name.

Career Highlights

Kristi A. Egland is associated with Sab Biotherapeutics, Inc., where she continues to advance her research and development efforts. Her work is crucial in the ongoing fight against viral diseases, showcasing her dedication to improving public health through innovative solutions.

Collaborations

Kristi collaborates with talented individuals in her field, including Hua Wu and Tom Luke. Their combined expertise enhances the research and development processes at Sab Biotherapeutics, Inc.

Conclusion

Kristi A. Egland is a trailblazer in immunoglobulin research, with her patent contributing to the fight against coronavirus disease. Her work exemplifies the impact of innovation in the medical field, and her collaborations further strengthen the advancements in this critical area.